Markets:

Overview

News

Currencies

International

Treasuries

Entrada Therapeutics, Inc. - Common Stock (NQ:TRDA)

10.82 -0.97 (-8.23%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Entrada Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Entrada Therapeutics Reports First Quarter 2023 Financial Results

May 10, 2023

From Entrada Therapeutics, Inc.

Via GlobeNewswire

Entrada Therapeutics Appoints Dr. Bernhardt Zeiher to its Board of Directors

April 04, 2023

From Entrada Therapeutics, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023 ↗

April 03, 2023

Via Benzinga

Entrada Therapeutics to Participate in Guggenheim Genomic Medicines and Rare Disease Conference

March 29, 2023

From Entrada Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 09, 2023

Via Benzinga

Entrada Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

March 06, 2023

From Entrada Therapeutics, Inc.

Via GlobeNewswire

Entrada Therapeutics to Participate in Cowen 43rd Annual Health Care Conference

February 27, 2023

From Entrada Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 16, 2023

Via Benzinga

Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 15, 2023

Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 14, 2023

Via Benzinga

Entrada Therapeutics Closes Agreement with Vertex to Discover and Develop Endosomal Escape Vehicle-Therapeutics for Myotonic Dystrophy Type 1 (DM1)

February 09, 2023

From Entrada Therapeutics, Inc.

Via GlobeNewswire

Entrada Therapeutics Announces Clinical Candidate, ENTR-601-45, for the Potential Treatment of People Living with Duchenne Muscular Dystrophy who are Exon 45 Skipping Amenable

January 09, 2023

ENTR-601-45 Expands Entrada’s Commitment to the Duchenne Community by Advancing a Potential Treatment for People Living with Duchenne Who are Exon 45 Skipping Amenable

From Entrada Therapeutics, Inc.

Via GlobeNewswire

Dow Jumps 150 Points; Crude Oil Rises 1% ↗

December 20, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Tuesday.

Via Benzinga

Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 20, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 20, 2022

Via Benzinga

Nasdaq Edges Lower; Gold Rises 1.5% ↗

December 20, 2022

U.S. stocks traded mixed midway through trading, with the S&P 500 and the Nasdaq Composite moving lower on Tuesday.

Via Benzinga

Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday ↗

December 20, 2022

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket ↗

December 20, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small...

Via Benzinga

Nike, General Mills And 3 Stocks To Watch Heading Into Tuesday ↗

December 20, 2022

With US stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Why Entrada Therapeutics Stock Is Diving After Hours ↗

December 19, 2022

Entrada Therapeutics Inc (NASDAQ: TRDA) shares are trading lower in Monday's after-hours session after the company said it received a clinical hold notice from the

Via Benzinga

Entrada Therapeutics Announces Clinical Hold on IND Application for ENTR-601-44 in Duchenne Muscular Dystrophy

December 19, 2022

From Entrada Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 08, 2022

Via Benzinga

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 13, 2022

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

Via Benzinga

Entrada Therapeutics Stock Gains On Licensing Pact With Vertex For Form Of Neuromuscular Disorder ↗

December 08, 2022

Via Benzinga

Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

December 08, 2022

Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.

Via Benzinga

Entrada Skyrockets On $250 Million Deal With Vertex In Muscular Dystrophy ↗

December 08, 2022

Entrada is working on drugs for forms of muscular dystrophy — now, with Vertex's help.

Via Investor's Business Daily

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 08, 2022

Via Benzinga

Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)

December 08, 2022

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Tesla, Deere And Some Other Big Stocks Moving Higher On Wednesday ↗

November 23, 2022

U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.